Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

SNDX Syndax Pharmaceuticals

24.030
-0.680-2.75%
Close 09/30 16:00 ET
24.0300.0000.00%
Post Mkt Price 09/30 16:02 ET
High
25.220
Open
24.620
Turnover
16.24M
Low
24.000
Pre Close
24.710
Volume
661.80K
Market Cap
1.36B
P/E(TTM)
126.47
52wk High
25.708
Shares
56.57M
P/E(Static)
52.24
52wk Low
13.270
Float Cap
1.09B
Bid/Ask %
0.00%
Historical High
27.850
Shs Float
45.42M
Volume Ratio
1.24
Historical Low
3.390
Dividend TTM
--
Div Yield TTM
--
P/B
3.76
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.46%
Amplitude
4.94%
Avg Price
24.531
Lot Size
1
Float Cap
1.09B
Bid/Ask %
0.00%
Historical High
27.850
Shs Float
45.42M
Volume Ratio
1.24
Historical Low
3.390
Dividend TTM
--
P/B
3.76
Dividend LFY
--
Turnover Ratio
1.46%
Amplitude
4.94%
Avg Price
24.531
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.
CEO: Mr. Michael A. Metzger
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...